Patents by Inventor Bei Ding

Bei Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230061838
    Abstract: The present disclosure provides dimeric antigen receptors (DAR) constructs that bind a CD20 target antigen, where the DAR construct comprises a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. The two polypeptide chains that make up the dimeric antigen receptors can dimerize to form an antigen binding domain. The dimeric antigen receptors have antibody-like properties as they bind specifically to a target antigen. The dimeric antigen receptors can be used for directed cell therapy.
    Type: Application
    Filed: August 16, 2022
    Publication date: March 2, 2023
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Henry Hongjun Ji, Wenzhong Guo, Yanliang Zhang, Bei Bei Ding, Gunnar F. Kaufmann
  • Publication number: 20220251168
    Abstract: The present disclosure provides dimeric antigen receptors (DAR) constructs that bind a BCMA target antigen, where the DAR construct comprises a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. The two polypeptide chains that make up the dimeric antigen receptors can dimerize to form an antigen binding domain. The dimeric antigen receptors have antibody-like properties as they bind specifically to a target antigen. The dimeric antigen receptors can be used for directed cell therapy.
    Type: Application
    Filed: March 3, 2022
    Publication date: August 11, 2022
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Henry Hongjun Ji, Wenzhong Guo, Yanliang Zhang, Bei Bei Ding, Gunnar F. Kaufmann
  • Publication number: 20200399393
    Abstract: The present disclosure provides dimeric antigen receptors (DAR) constructs comprising a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. The two polypeptide chains that make up the dimeric antigen receptors can dimerize to form an antigen binding domain. The dimeric antigen receptors have antibody-like properties as they bind specifically to a target antigen. The dimeric antigen receptors can be used for directed cell therapy.
    Type: Application
    Filed: September 4, 2020
    Publication date: December 24, 2020
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Henry Hongjun Ji, Wenzhong Guo, Yanliang Zhang, Gunnar F. Kaufmann, Bei Bei Ding
  • Publication number: 20140194589
    Abstract: A water-dispersible amphoteric polyurethane and a preparation method therefor. The water-dispersible amphoteric polyurethane is prepared from a polyisocyanate compound, a polyol compound, a dial compound having an anionic group or a potential anionic group, a compound having a tertiary or quaternary amine cationic group at least having two active H functional groups and a polyamine compound having a polyoxyethylene group. During preparation, the feeding order of the dial compound and the compound having a tertiary or low-molecular quaternary amine cationic group is controlled, and then neutralization and chain extension are performed, to obtain the target product. Also disclosed is a use of the water-dispersible amphoteric polyurethane in reinforcing concrete, wherein the water-dispersible amphoteric polyurethane is present in an amount of 0.1% to 5%, based on the total weight of the concrete.
    Type: Application
    Filed: July 8, 2011
    Publication date: July 10, 2014
    Applicant: JIANGSU RESEARCH INSTITUTE OF BUILDING SCIENCE CO. LTD
    Inventors: Changwen Miao, Bei Ding, Dongliang Zhou